Sign In
Buy AXGN
$42.21
+0.86 (+2.08%)
At Close: Jul 31, 2026
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
07:00am, Monday, 24'th Jun 2024
ALACHUA, Fla. and TAMPA, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, a
Strength Seen in AxoGen (AXGN): Can Its 5.4% Jump Turn into More Strength?
06:01am, Wednesday, 12'th Jun 2024
AxoGen (AXGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia
04:30pm, Tuesday, 28'th May 2024
Showcasing Axogen's Dedication to Fueling Ohio's Biotechnology Sector Growth Showcasing Axogen's Dedication to Fueling Ohio's Biotechnology Sector Growth
AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft
01:31pm, Friday, 17'th May 2024
AxoGen (AXGN) starts the process of BLA submission to the FDA for the approval of its Avance Nerve Graft.
AxoGen, Inc. (AXGN) Q1 2024 Earnings Call Transcript
01:21am, Sunday, 05'th May 2024
AxoGen, Inc. (NASDAQ:AXGN ) Q1 2024 Earnings Conference Call May 2, 2024 8:00 AM ET Company Participants Harold Tamayo - VP, Finance and IR Karen Zaderej - Chairman, CEO and President Nir Naor - CFO C
AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates
09:16am, Thursday, 02'nd May 2024
AxoGen (AXGN) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.10 per share a year ago.
Axogen, Inc Reports First Quarter 2024 Financial Results
07:00am, Thursday, 02'nd May 2024
ALACHUA, Fla. and TAMPA, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, to
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
04:50pm, Monday, 29'th Apr 2024
ALACHUA, Fla. and TAMPA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
07:00am, Tuesday, 16'th Apr 2024
ALACHUA, Fla. and TAMPA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,
AxoGen, Inc. (AXGN) Q4 2023 Earnings Call Transcript
11:03am, Tuesday, 05'th Mar 2024
AxoGen, Inc. (NASDAQ:AXGN ) Q4 2023 Earnings Call Transcript March 5, 2024 8:00 AM ET Company Participants Harold Tamayo - VP, Finance and IR Karen Zaderej - Chairman, CEO and President Nir Naor - CFO
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
07:00am, Tuesday, 05'th Mar 2024
ALACHUA, Fla. and TAMPA, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,
4 Must-Buy Stocks for Remarkable Earnings Acceleration
08:06am, Monday, 04'th Mar 2024
Some of the notable companies to have witnessed solid earnings acceleration as of now are Protagonist Therapeutics (PTGX), AxoGen (AXGN), Western Digital (WDC) and Phunware (PHUN).
AxoGen (AXGN) Is a Great Choice for 'Trend' Investors, Here's Why
09:51am, Wednesday, 28'th Feb 2024
AxoGen (AXGN) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "
AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?
10:16am, Monday, 26'th Feb 2024
AxoGen (AXGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
3 Best Stocks to Buy for Remarkable Earnings Acceleration
07:11am, Friday, 16'th Feb 2024
Invest in stocks such as AxoGen (AXGN), Western Digital (WDC) and Gen Digital (GEN) as of now for superb earnings acceleration.
